Retatrutide is a novel therapeutic/treatment/medicine agent under investigation for the management/treatment/control of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists/glucagon-like peptide-1 receptor agonists/glucose-dependent insulinotropic polypeptide agonists, which work by stimulating/activating/enhancing the r… Read More

Arriving in the field of weight management treatment, retatrutide represents a distinct method. Different from many available medications, retatrutide works as a twin agonist, at once engaging both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic substance (GIP) sensors. The simultaneous engagement promotes multiple advantageous effects, … Read More